Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Boitard

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Plos One|August 8, 2013
A simple and fast non-radioactive bridging immunoassay for insulin autoantibodiesIngrid Kikkas, Roberto Mallone, Nadia Tubiana-Rufi, et al.
Diabetes|July 4, 2018
Humanized Mouse Model to Study Type 1 DiabetesSandrine Luce, Sophie Guinoiseau, Alexis Gadault, et al.
Diabetologia|August 5, 2021
MAIT cell alterations in adults with recent-onset and long-term type 1 diabetesIsabelle Nel, Lucie Beaudoin, Zouriatou Gouda, et al.
Diabetes|October 15, 2011
Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetesSandrine Luce, François Lemonnier, Jean-Paul Briand, et al.
The Journal of Experimental Medicine|March 30, 2011
Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplayJulien Diana, Vedran Brezar, Lucie Beaudoin, et al.
Diabetologia|September 15, 2021
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomyPauline Faucher, Frédéric Beuvon, Daniela Fignani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2012
CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetesNadir Kadri, Eva Korpos, Shashank Gupta, et al.
Blood|July 1, 2011
acDCs enhance human antigen-specific T-cell responsesEmanuela Martinuzzi, Georgia Afonso, Marie-Claude Gagnerault, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal miceBéatrice Faideau, Jean-Paul Briand, Chantal Lotton, et al.
BMC Medicine|June 20, 2024
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkersJean Van Rampelbergh, Peter Achenbach, Richard David Leslie, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Plos One|August 8, 2013
A simple and fast non-radioactive bridging immunoassay for insulin autoantibodiesIngrid Kikkas, Roberto Mallone, Nadia Tubiana-Rufi, et al.
Diabetes|July 4, 2018
Humanized Mouse Model to Study Type 1 DiabetesSandrine Luce, Sophie Guinoiseau, Alexis Gadault, et al.
Diabetologia|August 5, 2021
MAIT cell alterations in adults with recent-onset and long-term type 1 diabetesIsabelle Nel, Lucie Beaudoin, Zouriatou Gouda, et al.
Diabetes|October 15, 2011
Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetesSandrine Luce, François Lemonnier, Jean-Paul Briand, et al.
The Journal of Experimental Medicine|March 30, 2011
Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplayJulien Diana, Vedran Brezar, Lucie Beaudoin, et al.
Diabetologia|September 15, 2021
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomyPauline Faucher, Frédéric Beuvon, Daniela Fignani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2012
CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetesNadir Kadri, Eva Korpos, Shashank Gupta, et al.
Blood|July 1, 2011
acDCs enhance human antigen-specific T-cell responsesEmanuela Martinuzzi, Georgia Afonso, Marie-Claude Gagnerault, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal miceBéatrice Faideau, Jean-Paul Briand, Chantal Lotton, et al.
BMC Medicine|June 20, 2024
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkersJean Van Rampelbergh, Peter Achenbach, Richard David Leslie, et al.
Pageof 9